연구동향 분석

New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients

방오영 홍근식 허지회 Jaseong Koo 권순억 유경호 배희준 이병철 윤병우 김종성 2014년

논문상세정보
인용/피인용
' New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • asians
  • atrial fibrillation
  • intracranialhemorrhage
  • neworalanticoagulants
  • stroke
  • warfarin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,034 0

0.0%

' New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients' 의 참고문헌

  • 뇌졸중 환자의 퇴원 후 한방 이용 실태 및 관련 요인
    최스미 대한뇌졸중학회지 5 (1) : 64 ~ 69 [2003]
  • Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation : a randomized trial
    Albers GW. JAMA 293 : 690 ~ 698 [2005]
  • Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial
    Schulman S. Ann Intern Med 155 : W201 ~ W203 [2011]
  • Use of herbal medicines by patients receiving warfarin
    Wong RS. Drug Saf 26 : 585 ~ 588 [2003]
  • The determinants of stroke phenotypes were different from the predictors(CHADS2 and CHA2DS2-VASc)of stroke in patients with atrial fibrillation : a comprehensive approach
    Oh S. BMC Neurol 11 : 107 ~ [2011]
  • The clinical implications of new oral anticoagulants : will the potential advantages be achieved?
    Phillips KW. Thromb Haemost 103 : 34 ~ 39 [2010]
  • Stroke prevention in atrial fibrillation: an Asian perspective
    Chiang CE Thromb Haemost 111 : 789 ~ 797 [2014]
  • Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998
    Ayala C Stroke 33 : 1197 ~ 1201 [2002]
  • Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
    Strazzullo P BMJ 339 : b4567 ~ [2009]
  • Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. – the ARISTOTLE-J study
    Ogawa S. Circ J 75 : 1852 ~ 1859 [2011]
  • Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study
    Hori M. Cir J 76 : 2104 ~ 2111 [2012]
  • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    Patel MR N Engl J Med 365 : 883 ~ 891 [2011]
  • Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
    Gallagher AM. Thromb Haemost 106 : 968 ~ 977 [2011]
  • Risk of hemorrhagic stroke in Asian American ethnic groups
    Klatsky AL. Neuroepidemiology 25 : 26 ~ 31 [2005]
  • Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    Shen AY. J Am Coll Cardiol 50 : 309 ~ 315 [2007]
  • Predicting the quality of anticoagulation during warfarin therapy : the basis for an individualized approach
    Boriani G. Chest 144 : 1437 ~ 1438 [2013]
  • Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients
    Takahashi H. Clin Pharmacol Ther 73 : 253 ~ 263 [2003]
  • Persistence with therapy among patients treated with warfarin for atrial fibrillation
    Gomes T. Arch Intern Med 172 : 1687 ~ 1689 [2012]
  • Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation : a science advisory for healthcare professionals from the American Heart Association/ American Stroke Association
    Furie KL. Stroke 43 : 3442 ~ 3453 [2012]
  • Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials
    Ntaios G Stroke 43 : 3298 ~ 3304 [2012]
  • Moving the tipping point : the decision to anticoagulate patients with atrial fibrillation
    Eckman MH. Circ Cardiovasc Qual Outcomes 4 : 14 ~ 21 [2011]
  • Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging : analysis of risk factors for multifocal signal loss lesions
    Lee SH. Stroke 33 : 2845 ~ 2849 [2002]
  • Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke
    Smith EE. Neurology 59 : 193 ~ 197 [2002]
  • Incidence of the major stroke subtypes : initial findings from the North East Melbourne Stroke Incidence Study(NEMESIS)
    Thrift AG. Stroke 32 : 1732 ~ 1738 [2001]
  • Health care and consumer choice : medical and alternative therapies
    Kelner M. Soc Sci Med 45 : 203 ~ 212 [1997]
  • Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version
    JCS Joint Working Group Circ J 74 : 2479 ~ 2500 [2010]
  • Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin : the SAMe-TT2R2 score
    Apostolakis S. Chest 144 : 1555 ~ 1563 [2013]
  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation : an analysis of the RE-LY trial
    Wallentin L. Lancet 376 : 975 ~ 983 [2010]
  • Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
    Rieder MJ. N Engl J Med 352 : 2285 ~ 2293 [2005]
  • Edoxaban versus warfarin in patients with atrial fibrillation
    Giugliano RP. N Engl J Med 369 : 2093 ~ 2104 [2013]
  • Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra-and inter-population dif-ferences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
    Takahashi H. Pharmacogenet Genomics 16 : 101 ~ 110 [2006]
  • Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
    Gomez-Outes A. BMJ 344 : e3675 ~ [2012]
  • Dabigatran versus warfarin in patients with atrial fibrillation
    Connolly SJ N Engl J Med 361 : 1139 ~ 1151 [2009]
  • Dabigatran versus warfarin : effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation
    Hori M. Stroke 44 : 1891 ~ 1896 [2013]
  • Costeffectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
    Harrington AR. Stroke 44 : 1676 ~ 1681 [2013]
  • Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack
    Kamel H. Stroke 43 : 881 ~ 883 [2012]
  • Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
    Kamel H. Neurology 79 : 1428 ~ 1434 [2012]
  • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation : a meta-analysis of randomised trials
    Ruff CT. Lancet 383 : 955 ~ 962 [2014]
  • Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation : a randomised, open-label, noninferiority trial
    Amadeus Investigators. Lancet 371 : 315 ~ 321 [2008]
  • Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk
    Charidimou A. Front Neurol 3 : 133 ~ [2012]
  • Cerebral microbleeds on MRI : prevalence, associations, and potential clinical implications
    Koennecke HC. Neurology 66 : 165 ~ 171 [2006]
  • Bleeding complications of oral anticoagulant treatment : an inception-cohort, prospective collaborative study(ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
    Palareti G. Lancet 348 : 423 ~ 428 [1996]
  • Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
    Connolly SJ Circulation 118 : 2029 ~ 2037 [2008]
  • Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages
    Wong KS. Neurology 60 : 511 ~ 513 [2003]
  • Apixaban versus warfarin in patients with atrial fibrillation
    Granger CB N Engl J Med 365 : 981 ~ 992 [2011]
  • Admission international normalized ratio and acute infarct volume in ischemic stroke
    Ay H. Ann Neurol 64 : 499 ~ 506 [2008]